Myelin-oligodendrocyte glycoprotein antibody-associated diseaseRomain Marignier, Bernhard Hemmer, Yael Hacohen et al.|The Lancet Neurology|2021Cited by 518
MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsyRyo Ogawa, Kazuo Fujihara, Ichiro Nakashima et al.|Neurology Neuroimmunology & Neuroinflammation|2017Cited by 432
CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implicationsKimihiko Kaneko, Masashi Aoki, Kyoichi Nomura et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 199
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study: Table 1Tetsuya Akaishi, Masashi Aoki, Douglas Kazutoshi Sato et al.|Journal of Neurology Neurosurgery & Psychiatry|2015Cited by 141
Treatment of MOG antibody associated disorders: results of an international survey.Daniel Whittam, A. Jacob, Eric C. Klawiter et al.|Research Padua Archive (University of Padua)|2020Cited by 139